Open-label study of mirtazapine orally disintegrating tablets in depressed patients in the nursing home

References

• Burrows AB, Salzman C, Satlin A, et al. A randomized, placebo-controlled trial of paroxetine in nursing home residents with non-major depression. Depress Anxiety 2002;15:102–10
   PubMed Web of Science ®Google Scholar
• Katz IR, Lesher E, Kleban M, et al. Clinical features of depression in the nursing home. Int Psychogeriatr 1989;1:5–15
   PubMedGoogle Scholar
• NIH consensus conference. Diagnosis and treatment of depression in late life. JAMA 1992;268:1018–24
   PubMed Web of Science ®Google Scholar
• Parmelee PA, Katz IR, Lawton MP. Depression among institutionalized aged: assessment and prevalence estimation. J Gerontol 1989;44:M22–9
   PubMedGoogle Scholar
• Parmelee PA, Katz IR, Lawton MP. Incidence of depression in long-term care settings. J Gerontol 1992;47:M189–96
   PubMedGoogle Scholar
• Payne JL, Sheppard JM, Steinberg M, et al. Incidence, prevalence, and outcomes of depression in residents of a long-term care facility with dementia. Int J Geriatr Psychiatry 2002;17:247–53
   PubMed Web of Science ®Google Scholar
• Rovner BW, German PS, Brant LJ, et al. Depression and mortality in nursing homes. JAMA 1991;265:993–6
   PubMed Web of Science ®Google Scholar
• Heston LL, Garrard J, Makris L, et al. Inadequate treatment of depressed nursing home elderly. J Am Geriatr Soc 1992;40:1117–22
   PubMed Web of Science ®Google Scholar
• Katz IR, Parmelee PA. Depression in the residential care elderly. In: Schneider LS, Reynolds CF, Lebowitz BD, et al., eds. Diagnosis and Treatment of Depression in Late Life: Results of the NIH Consensus Development Conference. Washington, DC: American Psychiatric Press, 1993:437–61
   Google Scholar
• Katz IR, Parmelee PA. Depression in the residential care elderly: an overview. In: Rubinstein RL, Lawton MO, eds. Shades of Gray: Depression among the Frail Elderly. New York: Springer, 1997:1–25
   Google Scholar
• Butler RN, Cohen G, Lewis MI, et al. Late-life depression: how to make a difficult diagnosis. Geriatrics 1997;52:37, 41–32, 47–50
   Google Scholar
• Montano CB. Recognition and treatment of depression in a primary care setting. J Clin Psychiatry 1994;55(Suppl 12):18–34; discussion 35–17
   PubMed Web of Science ®Google Scholar
• Montano CB. Primary care issues related to the treatment of depression in elderly patients. J Clin Psychiatry 1999;60(Suppl 20):45–51
   PubMed Web of Science ®Google Scholar
• Burrows AB, Satlin A, Salzman C, et al. Depression in a long-term care facility: clinical features and discordance between nursing assessment and patient interviews. J Am Geriatr Soc 1995;43:1118–22
   PubMed Web of Science ®Google Scholar
• Emery VO, Oxman TE. Update on the dementia spectrum of depression. J Clin Psychiatry 1992;149:305–17
   Google Scholar
• Mulsant BH, Ganguli M. Epidemiology and diagnosis of depression in late life. J Clin Psychiatry 1999;60(Suppl 20):9–15
   PubMed Web of Science ®Google Scholar
• Weiner MF, Edland SD, Luszczynska H. Prevalence and incidence of major depression in Alzheimer’s disease. Am J Psychiatry 1994;151:1006–9
   PubMed Web of Science ®Google Scholar
• Wragg RE, Jeste DV. Overview of depression and psychosis in Alzheimer’s disease. Am J Psychiatry 1989;146:577–87
   PubMed Web of Science ®Google Scholar
• Devanand DP, Sano M, Tang MX, et al. Depressed mood and the incidence of Alzheimer’s disease in the elderly living in the community. Arch Gen Psychiatry 1996;53:175–82
   PubMed Web of Science ®Google Scholar
• Salzman C. Practical considerations for the treatment of depression in elderly and very elderly long-term care patients. J Clin Psychiatry 1999;60(Suppl 20):30–3
   PubMed Web of Science ®Google Scholar
• Newhouse PA, Krishnan RR, Doraiswamy PM, et al. A double-blind comparison of sertraline and fluoxetine in depressed elderly outpatients. J Clin Psychiatry 2000;61:559–68
   PubMed Web of Science ®Google Scholar
• Montgomery SA. Efficacy and safety of the selective serotonin reuptake inhibitors in treating depression in elderly patients. Int Clin Psychopharmacol 1998;13(Suppl 5):S49–54
   PubMed Web of Science ®Google Scholar
• Salzman C, Wong E, Wright BC. Drug and ECT treatment of depression in the elderly. 1996–2001: a literature review. Biol Psychiatry 2002;52: 265–84
   PubMed Web of Science ®Google Scholar
• Zimmerman M, Mattia JI, Posternak MA. Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice? Am J Psychiatry 2002;159:469–73
   PubMed Web of Science ®Google Scholar
• Folstein MF, Folstein SE, McHugh PR. ‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–98
   PubMed Web of Science ®Google Scholar
• Linn BS, Linn MW, Gurel L. Cumulative illness rating scale. J Am Geriatr Soc 1968;16:622–6
   PubMed Web of Science ®Google Scholar
• Guy W. ECDEU Assessment Manual for Psychopharmacology. Publication ADM 76–338. Washington, DC: US Department of Health, Education, and Welfare; 1976:218–22
   Google Scholar
• Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56–62
   PubMed Web of Science ®Google Scholar
• Alexopoulos GS, Abrams RC, Young RC, et al. Cornell scale for depression in dementia. Biol Psychiatry 1988;23:271–84
   PubMed Web of Science ®Google Scholar
• Ott BR, Fogel BS. Measurement of depression in dementia: self vs clinician rating. Int J Geriatr Psychiatry 1992;7:899–904
   Web of Science ®Google Scholar
• Sleeper R, Bond CA, Rojas-Fernandez C. Psychotropic drugs and falls: new evidence pertaining to serotonin reuptake inhibitors. Pharmacotherapy 2000;20:308–17
   PubMed Web of Science ®Google Scholar
• Alessi CA, Ouslander JG, Maldague S, et al. Incidence and costs of acute medical conditions in long-stay incontinent nursing home residents. J Am Med Dir Assoc 2002;3:229–42
   PubMedGoogle Scholar
• Fihn SD. Acute uncomplicated urinary tract infection in women. N Engl J Med 2003;349: 259–266
   PubMed Web of Science ®Google Scholar
• Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc 1999;47:30–9
   PubMed Web of Science ®Google Scholar
• Street JS, Clark WS, Gannon KS, et al. Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group. Arch Gen Psychiatry 2000;57:968–76
   PubMed Web of Science ®Google Scholar
• Tariot PN, Cummings JL, Katz IR, et al. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer’s disease in the nursing home setting. J Am Geriatr Soc 2001;49:1590–9
   PubMed Web of Science ®Google Scholar
• Schatzberg AF, Kremer C, Rodrigues HE, et al. Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients. Am J Geriatr Psychiatry 2002;10:541–50
   PubMed Web of Science ®Google Scholar
• Hoyberg OJ, Maragakis B, Mullin J, et al. A double-blind multicentre comparison of mirtazapine and amitriptyline in elderly depressed patients Acta Psychiatr Scand 1996;93:184–90
   Google Scholar
• Roose SP, Sackeim HA. Clinical trials in late-life depression: revisited. Am J Geriatr Psychiatry 2002 10:503–5
   PubMed Web of Science ®Google Scholar